“…10 In vivo self-assembled nanomedicines undergo blood circulation, tissue penetration, targeted accumulation, and elimination in vitro . 11 In contrast to in vitro self-assembled nanodrugs, in situ constructed self-assembled nanodrugs circulate in a molecular state, “self-assembly-assisted target” to the lesion site, 12 and accumulate in the pathological site through the aggregation/assembly-induced retention (AIR) effect, 13 which reduces the problems of rapid excretion and extensive metabolism, resulting in lower systemic toxicity. 14 Therefore, the in situ construction of stimuli-responsive self-assembled nanomaterials provides new ideas and strategies for diagnosing and treating major diseases such as cancer.…”